Market cap
$2 Mln
Revenue (TTM)
$78 Mln
P/E Ratio
--
P/B Ratio
1.8
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -18.59 | -18.72 | -11.04 | -36.83 | -22.50 |
| EBIT | 72.26 | 14.20 | -123.95 | -299.11 | -223.16 |
| Net Profit | 110.60 | 15,251.85 | 28.89 | 20.47 | -247.71 |
| EPS | -- | -- | -- | -- | -- |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-22 | Dec-21 |
| EBIT-Margin
| -48.42 | -28.79 | -112.40 | -85.92 | 17.90 |
| Net Margin
| -190.22 | -190.22 | -64.63 | -- | -- |
| Return on equity
| -107.03 | -64.49 | -- | 624.34 | -758.52 |
| Return on Capital
| -1,597.97 | -959.00 | -- | -4,071.96 | -571.14 |
| Return on Assets
| -78.76 | -47.39 | -42.50 | -56.28 | -99.72 |
| Debt to Equity (x)
| -- | -- | -0.54 | -0.40 | 1.21 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Surgalign Holdings (SRGA)
|
--
|
-4,071.96
|
-571.14
|
-150.82
|
-0.54
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
--
--
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Surgalign Holdings (SRGA)
|
--
|
624.34
|
-758.52
|
-186.91
|
-0.68
|
|
Peer Median
|
4.94
|
--
|
--
|
--
|
--
|
ROA
-42.50
Lower than Peers by 44.95
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Surgalign Holdings (SRGA)
|
-42.50
|
-56.28
|
-99.72
|
-80.26
|
-0.35
|
|
Peer Median
|
2.45
|
--
|
--
|
--
|
--
|
EBIT Margin
-112.40
Lower than Peers by 120.88
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Surgalign Holdings (SRGA)
|
-112.40
|
-85.92
|
17.90
|
-77.24
|
-1.00
|
|
Peer Median
|
8.47
|
--
|
--
|
--
|
--
|
Net Margin
-64.63
Lower than Peers by 69.30
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Surgalign Holdings (SRGA)
|
-64.63
|
-66.61
|
-135.81
|
-190.22
|
-0.45
|
|
Peer Median
|
4.68
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Surgalign Holdings (SRGA)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-11.04
Lower than Peers by 19.52
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Surgalign Holdings (SRGA)
|
-11.04
|
-0.09
|
-0.11
|
-0.64
|
--
|
|
Peer Median
|
8.49
|
--
|
--
|
--
|
--
|
EBIT Growth
-123.95
Lower than Peers by 134.60
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Surgalign Holdings (SRGA)
|
-123.95
|
-534.91
|
120.61
|
-2,696.80
|
-143.26
|
|
Peer Median
|
10.65
|
--
|
--
|
--
|
--
|
Net Profit Growth
28.89
Higher than Peers by 15.33
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Surgalign Holdings (SRGA)
|
28.89
|
55.57
|
36.71
|
-15,435.60
|
--
|
|
Peer Median
|
13.55
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
-0.54
Lower than Peers by 0.94
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Surgalign Holdings (SRGA)
|
-0.54
|
-0.40
|
1.21
|
0.03
|
0.27
|
|
Peer Median
|
0.40
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Surgalign Holdings (SRGA)
|
--
|
--
|
1.21
|
0.03
|
0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.67
Lower than Peers by 0.15
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Surgalign Holdings (SRGA)
|
2.67
|
2.68
|
1.96
|
2.23
|
3.14
|
|
Peer Median
|
2.83
|
--
|
--
|
--
|
--
|
Quick Ratio
2.00
Lower than Peers by 0.05
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Surgalign Holdings (SRGA)
|
2.00
|
1.84
|
1.47
|
1.74
|
1.22
|
|
Peer Median
|
2.05
|
--
|
--
|
--
|
--
|
Interest Coverage
-50.10
Lower than Peers by 55.06
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Surgalign Holdings (SRGA)
|
-50.10
|
-69.81
|
0.16
|
-2,535.16
|
-1.01
|
|
Peer Median
|
4.96
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
17.69
Higher than Peers by 1.23
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Surgalign Holdings (SRGA)
|
17.69
|
19.59
|
21.21
|
26.63
|
18.61
|
|
Peer Median
|
16.46
|
--
|
--
|
--
|
--
|
Asset Turnover
0.66
Higher than Peers by 0.15
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Surgalign Holdings (SRGA)
|
0.66
|
0.84
|
0.73
|
0.42
|
0.78
|
|
Peer Median
|
0.50
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Surgalign Holdings (SRGA)
|
--
|
78.54
|
93.42
|
142.45
|
67.98
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Surgalign Holdings (SRGA)
|
--
|
192.36
|
300.82
|
540.84
|
278.93
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Surgalign Holdings (SRGA)
|
--
|
78.45
|
144.89
|
164.88
|
68.16
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Surgalign Holdings (SRGA)
|
--
|
192.45
|
249.35
|
518.41
|
278.74
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Book Value
1.79
Lower than Peers by 2.00
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Surgalign Holdings (SRGA)
|
1.79
|
--
|
--
|
--
|
--
|
|
Peer Median
|
3.79
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Surgalign Holdings (SRGA)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-0.60
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Surgalign Holdings (SRGA)
|
-0.60
|
0.09
|
-2.21
|
0.60
|
3.24
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
2
Lower than Peers by 539
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Surgalign Holdings (SRGA)
|
2
|
--
|
--
|
--
|
--
|
|
Peer Median
|
540
|
--
|
--
|
--
|
--
|